BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2006
View Archived Issues
Studies detail pharmacokinetics, efficacy of valopicitabine
Read More
LB-80380 safe and active in lamivudine-resistant hepatitis B infection
Read More
R-1626 safe and active in chronic hepatitis C
Read More
HCV-796 well tolerated in healthy subjects
Read More
Study reveals activity of CPG-10101 alone and with peginterferon in hepatitis C
Read More
Epratuzumab safe, effective in systemic lupus erythematosus
Read More
Pfizer presents novel orally active GnRH receptor antagonist
Read More
Genaera updates findings from phase II trials of Evizon
Read More
Positive preclinical findings for antiobesity drug candidate trodusquemine
Read More
tgAAC-09 studied for prevention of HIV in Zambia
Read More
AstraZeneca and Abraxis BioScience sign agreements for Abraxane and anesthetics
Read More
A.P. Pharma begins phase III study of APF-530
Read More
New phase II trial to evaluate INS-50589 Antiplatelet in CABG patients
Read More
Chronogen cleared to begin phase I/II study of CHGN-111 in Canada
Read More
Ilypsa grants Astellas Japanese rights to ILY-101
Read More
Oglemilast for asthma and COPD enters phase II
Read More
Pirfenidone begins phase III CAPACITY program in IPF
Read More
ImQuest inlicenses piperazine compounds from Samjin
Read More
PC-DAC:Exendin-4 data support once-weekly or less frequent dosing
Read More
ISIS-301012 reduces apoB-100 in preclinical and clinical studies
Read More
NBI-56418 shows robust treatment effect in endometriosis
Read More
Actemra filed for rheumatoid arthritis in Japan
Read More
Epogin approved for anemia in premature infants
Read More
European CHMP hands down positive opinion for Tysabri in MS
Read More
Approvable letter for Nuvigil
Read More
Myozyme receives FDA approval for Pompe disease
Read More
Research with PA-082 gives insight into the mechanism of action of partial PPARgamma agonists
Read More
Recent patents cover therapeutic agents for neurological disorders
Read More
Novel agents for treating diabetes disclosed in recent patents
Read More
Novel analgesic agents disclosed in recent Gruenenthal and Janssen patents
Read More
